Double trouble for cannabis stocks? Double down on REITs?

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Last Wednesday in an a post, we noted that our 30-day Pharmaceuticals Indicator had peaked on Tuesday. As it turned out, the indicator has since moved back up and peaked again. This adds an extra degree of uncertainty to the prospect that a base for the group may have been established. Once the 30-day indicator moves below the 60-day indicator we will have a bit more confidence that investor anxiety has settled down in the space.


If we are right about the poor outlook for stocks generally going forward, some names in the Pharmaceuticals industry could provide defensive exposure during a bear market. Unfortunately, many stocks in the group are in marijuana-related businesses with excessive valuations limiting their attractiveness as defensive plays. Nevertheless, we have removed the idea of hedging long positions in cannabis stocks with a partial short position in the Horizons Marijuana Life Sciences ETF (HMMJ) from our #3 INK core investment theme of Watching for stock-specific opportunities in Healthcare and Technology.

REITs on the other hand, do not generally suffer from high valuations. That may help explain why insider buying in the group has shot up recently even though REITs are generally nowhere near their 52-week lows.


Insiders may also be sensing an end to rate hikes in Canada and the United States which would tend to benefit the group. However, in an economic slowdown some REITs may face financing risk if their mortgages are up for renewal during a contracting credit environment. Consequently, balance sheet quality will be key for individual names should the economy slow as we expect it will.

This is a based on a partial excerpt from today's INK market report (The Fed has probably already killed global economic growth) made available to INK Research subscribers and Canadian Insider Club members before the market open. Click here for Club membership subscription information.

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).